Comparing two anesthesia techniques in bariatric surgery
External Oblique Intercostal Block Versus Erector Spinae Plane Block in Laparoscopic Bariatric Surgery: A Randomized Controlled Trial
This study is testing which anesthesia technique works better for pain management and reduces opioid use in people having laparoscopic bariatric surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, Governorate) |
| Trial ID | NCT06168903 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of two anesthesia techniques, the external oblique intercostal (EOI) block and the erector spinae block (ESPB), in patients undergoing laparoscopic bariatric surgery. It is a randomized, controlled, double-blinded trial conducted at Cairo University Hospital. Participants will be randomly assigned to receive either the EOI block or ESPB, and their intraoperative opioid consumption, postoperative pain control in the first 24 hours, and need for rescue analgesics will be evaluated. The study aims to determine which technique provides better pain management and reduces opioid use.
Who should consider this trial
Good fit: Ideal candidates are obese patients aged 18 to 70 with a BMI of 35 kg/m2 or higher and scheduled for laparoscopic bariatric surgery.
Not a fit: Patients with severe comorbidities, coagulopathy, or those unable to comprehend pain assessment tools may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management and reduced opioid consumption for patients undergoing bariatric surgery.
How similar studies have performed: Other studies have shown promising results with similar anesthesia techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Obese patients of any gender with a body mass index (BMI) of ≥ 35 kg/m2 with comorbidities or \> 40 kg/m2 and American Society of Anesthesiologists (ASA) physical status I-III and aged between 18 and 70 years scheduled for laparoscopic bariatric surgery, that is, sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgery. Exclusion Criteria: * Coagulopathy, infection at the injection site, allergy to local anesthetics, severe hepatic or renal disease, severe cardiopulmonary disease (≥ ASA IV), diabetic or other neuropathies, patients receiving opioids for chronic analgesic therapy, and inability to comprehend visual analogue scale (VAS).
Where this trial is running
Cairo, Governorate
- Cairo university Hospitals. kasralainy — Cairo, Governorate, Egypt (Recruiting)
Study contacts
- Study coordinator: Nagy malak
- Email: nagymalak12345@gmail.com
- Phone: 01552480258
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.